FDA Approves MYCOPHENOLATE MOFETIL — Wuxi Fortune Pharmaceutical Co.,Ltd.
Wuxi Fortune Pharmaceutical has secured FDA approval for its generic Mycophenolate Mofetil (ANDA 214079), signals an escalation in its U.S. market presence. The approval will likely bolster the company's profitability while intensifying competitive pressure in the oral immunosuppressants sector.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day